Here is the latest shareholding Pattern of CORAL LAB.. For more details, see the CORAL LAB. financial fact sheet and CORAL LAB. share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 19.97 | 19.97 | 19.97 | 19.97 | 19.97 | 19.97 | 19.97 | 19.97 | |
Foreign Promoters | % | 51.54 | 51.54 | 51.54 | 51.54 | 51.54 | 51.54 | 51.54 | 51.54 | |
Total Promoters | % | 71.51 | 71.51 | 71.51 | 71.51 | 71.51 | 71.51 | 71.51 | 71.51 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.42 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.42 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | |
Bodies Corporate | % | 1.86 | 1.88 | 1.88 | 1.56 | 1.59 | 1.55 | 1.60 | 1.61 | |
Individuals | % | 21.33 | 21.01 | 20.84 | 21.23 | 21.16 | 20.90 | 20.87 | 20.82 | |
NRIs/OCBs | % | 1.92 | 2.44 | 2.31 | 2.23 | 2.26 | 2.53 | 2.45 | 2.47 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.96 | 3.02 | 3.32 | 3.33 | 3.34 | 3.37 | 3.43 | 3.45 | |
Total Non-Institution | % | 28.07 | 28.35 | 28.35 | 28.35 | 28.35 | 28.35 | 28.35 | 28.35 | |
Total Public | % | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Indian share markets continued the momentum as the session progressed and ended the higher.